Novo Holdings, the controlling shareholder of Novo Nordisk, hopes to double the size of its recently acquired contract ...

Novo Nordisk has started building its first brand-new manufacturing facility in Denmark since the millennium, saying it plans to spend around DKK 8.5 billion ($1.2 billion) on the plant.

Novavax NVAX announced that it has agreed to sell its manufacturing facility ... sale opportunities for the plant to save operating costs. If the deal with Novo Nordisk goes through, the company ...

The new plant will be one of the largest manufacturing investments in Novo Nordisk’s history and will add 1.4 million sq ft of production space for aseptic manufacturing and finished production ...

It's still investing billions in spinning up new manufacturing facilities to ensure that supply capacity stops being a constraint on growth. What's more, Novo Nordisk is in exactly the same ...

Novo Holdings plans to double its newly acquired contract drugmaker, Catalent, within five years, focusing on U.S. manufacturing. The $16.5 billion acquisition is aimed at enhancing supply chains amid ...

Eli Lilly certainly has the strongest growth at this time, which is now supported by robust manufacturing compared to Novo Nordisk. The latter has year-over-year revenue growth of 26%, while the ...

While the recent launches of GLP-1 drugs from Novo Nordisk and Eli ... pharmaceutical ingredients plant in Lebanon, Indiana, to plans for a $4.5 billion R&D and manufacturing facility—also ...